Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma
Authors not listed
Mingzhi Zhang · 2017
Abstract
To explore the clinical features and efficacy evaluation of large b-cell lymphoma in old age.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Anonymous. (2017). Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma. <em>Mingzhi Zhang</em>. https://clinicaltrials.gov/study/NCT03513601
Vancouver
Anonymous. Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma. Mingzhi Zhang. 2017.
BibTeX
@misc{anon2017Treatm,
title = {Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma},
author = {Anonymous},
journal = {Mingzhi Zhang},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Xiaohui He 2025
Open access · US-GOV
A Multicenter, Prospective Phase Ⅱ Clinical Study of R-mini-MCOP(Rituximab / Mitoxantrone Liposome / Cyclophosphamide / Vincristine / Prednisone) in the Treatment of Elderly, Previously Untreated Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 2011
Open access · US-GOV
Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma: a Phase II Multicenter Study of the Fondazione Italiana Linfomi (FIL)
H. Lee Moffitt Cancer Center and Research Institute 2013
Open access · US-GOV
Pilot Study of Brentuximab Vedotin in CD30 Positive EBV Positive Diffuse Large B-Cell Lymphomas of the Elderly
Ruijin Hospital 2020
Open access · US-GOV
The Efficacy and Safety of Zanubrutinib, Lenalidomide and Rituximab (ZR2) Regimen in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)
Sun Yat-sen University 2026
Open access · US-GOV
A Multicenter, Phase Ib/II Clinical Study of Polatuzumab Vedotin in Combination With Rituximab and Chidamide for Untreated Elderly Diffuse Large B-cell Lymphoma Patients With Double Expression of MYC and BCL2
The First Affiliated Hospital with Nanjing Medical University 2012
Open access · US-GOV